Humacyte, Inc. (HUMA)

Humacyte, Inc. (HUMA) is a healthcare company (biotechnology) based in the United States. The share price is $0.50, down 7.27% on the day, which values the company at $139.18M. Price as of 18 Nov 2026, 11:36 UTC, from Yahoo Finance.

Key facts

Share price
$0.50−7.27% today
Market value
$139.18M
200-week average
$2.8582% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Humacyte, Inc. in more detail

HUMA trades at -2.0× next year's expected earnings, 58.1× sales. It sits 82% below its 200-week average of $2.85.

Worth checking: Altman Z in the distress zone; Weak Piotroski score.

Humacyte, Inc. (HUMA): questions and answers

What is Humacyte, Inc.'s market cap?

Humacyte, Inc. is valued at $139.18M at a share price of $0.50.

Is HUMA above its 200-week moving average?

No. HUMA is 82.4% below its 200-week average of $2.85. Long-term investors watch that line because strong companies rarely trade below it for long.

Does HUMA pay a dividend?

Humacyte, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Humacyte, Inc. (HUMA) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/HUMA

Underlying data: Yahoo Finance; company filings with the SEC.